JuliaBiswas
commented on a stock · Feb 4, 2024 19:05
$Regenxbio (RGNX.US)$ pivotal topline result from CAMPSIIT t...
$Regenxbio (RGNX.US)$pivotal topline result from CAMPSIIT trial are coming. RGX-121 for the treatment a rare genetic disease showing meaningful results. Prior FDA granted Renerative medicine advanced therapy decignition for RGX-121. Let’s see…
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.